Spectrin beta 3 Antibody (SPTBN2/3142R) [mFluor Violet 610 SE]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-08442MFV610
Recombinant Monoclonal Antibody
![Spectrin beta 3 Antibody (SPTBN2/3142R) [mFluor Violet 610 SE]](https://resources.bio-techne.com/images/products/nbp3-08442mfv610_rabbit-spectrin-beta-3-mab-sptbn2-3142r-mfv610-se-672023972938.png "Spectrin beta 3 Antibody (SPTBN2/3142R) [mFluor Violet 610 SE] [NBP3-08442MFV610] -")
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
ELISA, Flow Cytometry, Immunocytochemistry/ Immunofluorescence, Immunohistochemistry-Paraffin, Western Blot
Label
mFluor Violet 610 SE (Excitation = 421 nm, Emission = 613 nm)
Antibody Source
Recombinant Monoclonal Rabbit IgG Clone # SPTBN2/3142R
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for Spectrin beta 3 Antibody (SPTBN2/3142R) [mFluor Violet 610 SE]
Immunogen
Recombinant fragment (around aa356-475) of human Spectrin beta 3 protein (exact sequence is proprietary) (Uniprot: O15020)
Localization
Cell Surface
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for Spectrin beta 3 Antibody (SPTBN2/3142R) [mFluor Violet 610 SE]
Spectrin beta 3 Antibody (SPTBN2/3142R) [mFluor Violet 610 SE] [NBP3-08442MFV610] -
Spectrin beta 3 Antibody (SPTBN2/3142R) [mFluor Violet 610 SE] [NBP3-08442MFV610] - Vial of mFluor Violet 610 conjugated antibody. mFluor Violet 610 is optimally excited at 421 nm by the Violet laser (405 nm) and has an emission maximum of 613 nm.Applications for Spectrin beta 3 Antibody (SPTBN2/3142R) [mFluor Violet 610 SE]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Immunocytochemistry/ Immunofluorescence
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: beta-III Spectrin
Mutations in this gene cause a form of spinocerebellar ataxia, SCA5, that is characterized by neurodegeneration, progressive locomotor incoordination, dysarthria, and uncoordinated eye movements. Mutations in spectrins are a previously unknown cause of ataxia and neurodegenerative disease that affect membrane proteins involved in glutamate signaling. Spectrin-beta IIIs have been recognized as ataxia disease genes and their mutations cause spinocerebellar ataxia type 5 (SCA5).
Long Name
Spectrin Beta, Non-Erythrocytic 2
Alternate Names
GTRAP41, SCA5, SCAR14, Spectrin beta 3, Spectrin beta III, SPTBN2
Gene Symbol
SPTBN2
Additional beta-III Spectrin Products
Product Documents for Spectrin beta 3 Antibody (SPTBN2/3142R) [mFluor Violet 610 SE]
Product Specific Notices for Spectrin beta 3 Antibody (SPTBN2/3142R) [mFluor Violet 610 SE]
mFluor(TM) is a trademark of AAT Bioquest, Inc. This conjugate is made on demand. Actual recovery may vary from the stated volume of this product. The volume will be greater than or equal to the unit size stated on the datasheet.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...